Acetazolamide EQL Pharma now approved for sale
The drug Acetazolamide EQL Pharma has now been approved for sale by the Swedish Medicines Agency. The product is expected to be launched around the turn of the year 2018/2019.Acetazolamide EQL Pharma is used as a short-term treatment for eye surgery when there is a risk of increased pressure inside the eye. Acetazolamide EQL Pharma is also used as an add-on therapy for the treatment of green starr (glaucoma) and before surgery of acute narrow-angle glaucoma. The drug Acetazolamide EQL Pharma is a niche generic, where EQL Pharma becomes the only and first generic on the Swedish market for